Our firm is about people. That is our motto and that will always be our reality.
We do our best to get to know our clients, understand their situations, and get them the compensation they deserve.
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Without our team, we would’nt be able to provide our clients with anything close to the level of service they receive when they work with us.
The TorHoerman Law Team commits to the sincere belief that those injured by the misconduct of others, especially large corporate profit mongers, deserve justice for their injuries.
Our team is what has made TorHoerman Law a very special place since 2009.
Gadolinium (Gd) is a silvery-white, malleable and ductile rare-earth metal.
Because of the extremely high neutron cross-section of Gadolinium, this element is very effective for use with:
The chemical medium helps to provide clear and detailed pictures of internal organs that can then be used to “more accurately report on how your body is working and whether there is any disease or abnormality present.”
Gadolinium contrast dyes were approved for use in MRI scans in 1988.
It is now the most commonly used chemical medium for MRIs.
TorHoerman Law is no longer accepting clients for this litigation.
The following are five (5) well-known Gadolinium Contrast Dyes on the market:
NSF is a rare diagnosis.
There have been no reports of NSF in patients with normal kidney function or with those with mild-to-moderate kidney insufficiency.
However, if you suspect you may have kidney issues, you should be screened prior to receiving one of these imaging agents.
Furthermore, the recommended dose should not be exceeded and enough time should elapse to ensure that a dose has been eliminated from the body before the agent is used again.
In May 2006, the Danish Medicines Agency was one of the first groups to report NSF traces.
The agency reported 25 cases of NSF occurring in Denmark and Austria alone.
In May 2007, Dr. Melanie Blank, an FDA kidney specialist, issued a report concluding that:
An “undeniable and strong association” existed between contrast agents containing Gadolinium and NSF.
Originally thought to be a skin disorder, the diagnosis was termed Nephrogenic Fibrosing Dermopathy (NFD).
Gradually, the diagnosis produced wider symptoms and it is now considered a systemic disorder referred to as Nephrogenic Systemic Fibrosis (NSF).
Some of the initial signs of NSF/NSD are:
Symptoms are similar to NSF, but vary in a few notable ways:
If you have been injured as a consequence of Gadolinium dye used in an MRI, please contact our office at (888) 508-6752 for a free, no-obligation Gadolinium lawsuit consultation.
TorHoerman Law is no longer accepting Gadolinium Nephrogenic Systemic Fibrosis (NSF) cases.
NSF is a disease also caused by Gadolinium, with the first diagnosis occurring in 1997.
Currently, the Center for Disease Control has information about 315 patients with NSF.
Sadly, at the present time, there are more questions than there are answers about the disease.
There are very few effective treatments for NSF, and there is no cure.
Gadolinium contrast agents, used to enhance MRI films, can be extremely dangerous.
Over the past several years it has become apparent that Gadolinium contrast dyes can cause two separate diseases:
Gadolinium Deposition Disease occurs in individuals with normal or near-normal renal function “who develop persistent symptoms that arise within a few hours to two months after the administration of Gadolinium-based contrast agents (GBCAs).”
In order to diagnose individuals with the disease, a urine test must be administered that confirms the presence of Gadolinium in the body.
This test should be administered 30 or more days after the most recent GBCA was used.
Until recently, a diagnosis for patients with normal to near-normal renal function did not exist, making the disease a relatively new concept.
It is unclear how many individuals actually suffer from Gadolinium Deposition Disease.
Owner & Attorney - TorHoerman Law
Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.
In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.
In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.
In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.
In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?